Wissenschaftliche Arbeiten

Dr. Öğr. Üyesi Hüseyin Saffet Beköz

77 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil

  1. Universal Use of Novel Oral Anticoagulant Prophylaxis in Myeloma Patients Undergoing IMiD-Based Therapy: Real-World Experience

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15020453 PMID 41598391 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  2. Temporal dynamics and predictors of carbapenem-resistant gram-negative bacteria in bloodstream infections in hematological patients

    BMC Infectious Diseases, 2026

    DOI 10.1186/s12879-026-13082-3 PMID 41820858 Frei zugänglicher VolltextQuelle: OpenAlex

  3. Venetoclax-based treatment in adult relapsed/refractory acute lymphoblastic leukemia and lymphoblastic lymphoma: a single-center real-world experience

    Journal of Health Sciences and Medicine, 2026

    DOI 10.32322/jhsm.1825832 Frei zugänglicher VolltextQuelle: OpenAlex

  4. Long-Term Complete Remission Following Lenalidomide-Augmented IVAC/ICE Therapy and Allogeneic Hematopoietic Stem Cell Transplantation in Hepatosplenic T-Cell Lymphoma: A Case Report

    Turkish Journal of Hematology, 2026

    DOI 10.4274/tjh.galenos.2026.13284 PMID 41914439 Frei zugänglicher VolltextQuelle: OpenAlex

  5. Real-World Experience with Belinostat in the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma

    Annals of Medical Research, 2026

    DOI 10.5455/annalsmedres.2025.07.193 Frei zugänglicher VolltextQuelle: OpenAlex

  6. A Multi-Targeted Strategy for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: Real-World Outcomes of the ViPOR Regimen

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15145401 PMID 42513315 Frei zugänglicher VolltextQuelle: OpenAlex

  7. Enterovirus Encephalitis Developing After Treatment for Follicular Lymphoma: A Case Report

    SN Comprehensive Clinical Medicine, 2026

    DOI 10.1007/s42399-026-02560-z Quelle: OpenAlex

  8. Real-World Effectiveness and Renal Safety of Foscarnet for CMV Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15166365 PMID 42652768 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  9. Real-World Outcomes of Belinostat in Relapsed Refractory T-Cell Lymphomas: A Report from the Lymphoma Study Group of Turkish Society of Hematology

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15166350 PMID 42652754 Frei zugänglicher VolltextQuelle: OpenAlex

  10. When high dose methotrexate stops working, a successful bridge to transplant with TEDDI-R in a case of secondary CNS lymphoma

    Annals of Hematology, 2025

    DOI 10.1007/s00277-025-06285-2 PMID 40016397 Frei zugänglicher VolltextQuelle: OpenAlex

  11. Successful treatment of steroid-refractory gastrointestinal GVHD with ruxolitinib in a patient after autologous stem cell transplantation: a case report

    International Journal of Hematology, 2025

    DOI 10.1007/s12185-025-04073-2 PMID 41004031 Quelle: OpenAlex

  12. Relaps/refrakter akut lenfoblastik lösemi ve lenfoblastik lenfomada venetoklaks temelli tedavi: tek merkez gerçek yaşam deneyimi

    DergiPark (Istanbul University), 2025

    Quelle: OpenAlex

  13. Cutaneous cytomegalovirus infection: a case report

    Skin Health and Disease, 2025

    DOI 10.1093/skinhd/vzaf057 PMID 42222707 Frei zugänglicher VolltextQuelle: OpenAlex

  14. Antifungal prophylaxis in high-risk patients with hematologic malignancy: a comparison of practice and guidelines in Türkiye

    Turkish Journal of Medical Sciences, 2025

    DOI 10.55730/1300-0144.5942 PMID 40104305 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  15. Clinicopathological features of splenectomy cases: an 11-year experience with rare and common disorders

    VIRCHOWS ARCHIV, 2025

    Quelle: ORCID

  16. Atypical presentation of PJP: hypercalcemia and kidney injury in an allogeneic stem cell transplant recipient

    BMC Infectious Diseases, 2024

    DOI 10.1186/s12879-024-10074-z PMID 39448907 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  17. Plerixafor in autologous stem cell transplantation: Does it affect engraftment kinetics?

    Transfusion and Apheresis Science, 2023

    DOI 10.1016/j.transci.2023.103809 PMID 37690861 2 Zitationen (Europe PMC) Quelle: OpenAlex

  18. THE IMPORTANCE OF CLINICAL AND LABORATORY PARAMETERS OF BONE MARROW METASTASIS IN PATIENTS WITH SOLID MALIGNANCY-SINGLE CENTER EXPERIENCE

    Karya Journal of Health Science, 2023

    DOI 10.52831/kjhs.1271864 Frei zugänglicher VolltextQuelle: OpenAlex

  19. Glofitamab in relapsed/refractory diffuse large B‐cell lymphoma: Real‐world data

    Hematological Oncology, 2023

    DOI 10.1002/hon.3174 PMID 37211991 31 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  20. Comparison of different plerixafor-based strategies for adequate hematopoietic stem cell collection in poor mobilizers

    The European Research Journal, 2023

    DOI 10.18621/eurj.1231251 Frei zugänglicher VolltextQuelle: OpenAlex

  21. The role of obesity on autologous bone marrow transplant and post-transplant outcomes

    Journal of Surgery and Medicine, 2023

    DOI 10.28982/josam.7664 Frei zugänglicher VolltextQuelle: ORCID

  22. Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from Turkey

    Annals of Hematology, 2022

    DOI 10.1007/s00277-022-05052-x PMID 36401621 7 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  23. Comparison of Efficacy and Safety of Generic Plerixafor Vs Original Plerixafor in the Mobilization of Myeloma Patients

    Blood, 2022

    DOI 10.1182/blood-2022-168558 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  24. CD5 as a prognostic marker in patients with diffuse large B-cell lymphoma: a multicenter study

    Journal of Hematopathology, 2022

    DOI 10.1007/s12308-022-00523-6 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  25. Prognostic Factors and Intensive Care Outcome in Post-Transplant Phase of Hematopoietic Stem Cell Transplantation

    Indian Journal of Hematology and Blood Transfusion, 2022

    DOI 10.1007/s12288-022-01575-5 PMID 37006979 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  26. P1227: POLATUZUMAB VEDOTIN, RITUXIMAB, AND BENDAMUSTINE COMBINATION IN RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A REAL-WORLD DATA FROM TURKEY

    HemaSphere, 2022

    DOI 10.1097/01.hs9.0000847772.34235.05 Frei zugänglicher VolltextQuelle: OpenAlex

  27. Otolog Kök Hücre Transplantasyonunda Sitomegalovirüs (CMV) ve Hepatit B (HBV) Reaktivasyonu: Tek Merkez Deneyimi

    LLM Dergi, 2022

    DOI 10.5578/llm.20229802 Frei zugänglicher VolltextQuelle: OpenAlex

  28. Preliminary Report of the Academic CAR-T (ISIKOK-19) Cell Clinical Trial in Turkey: Characterization of Product and Outcomes of Clinical Application

    Turkish Journal of Hematology, 2022

    DOI 10.4274/tjh.galenos.2022.2022.0193 PMID 35848614 7 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  29. Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma: Real World Data

    Blood, 2022

    DOI 10.1182/blood-2022-165385 9 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  30. Evaluation of Neurological Imaging After Hematopoietic Stem Cell Transplantation In Adults

    Eastern Journal of Medicine, 2022

    DOI 10.5505/ejm.2022.54765 Frei zugänglicher VolltextQuelle: ORCID

  31. Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies

    Turkish Journal of Hematology, 2021

    DOI 10.4274/tjh.galenos.2021.2021.0287 PMID 34521187 7 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  32. A Real-life Turkish Experience of Venetoclax Treatment in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia

    Clinical Lymphoma Myeloma & Leukemia, 2021

    DOI 10.1016/j.clml.2021.04.004 PMID 34059487 9 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  33. COVID-19 infection in patients with acute leukemia; Istanbul experience.

    Europe PMC (PubMed Central), 2021

    PMID 34540352 11 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  34. Does Immunohistochemically CD5 Positivity Matter in Diffuse Large B-Cell Lymphoma Patients? Turkish Multicenter Study

    Research Square, 2021

    DOI 10.21203/rs.3.rs-987276/v1 Frei zugänglicher VolltextQuelle: ORCID

  35. Preliminary report of academic CAR-T (ISIKOK-19) cell clinical trial in Turkey: Characterization of product and outcomes of clinical application

    Medrxiv, 2021

    DOI 10.1101/2021.09.23.21263731 Frei zugänglicher VolltextQuelle: ORCID

  36. REPLY FROM THE AUTHORS

    TURKISH JOURNAL OF HEMATOLOGY, 2021

    Quelle: ORCID

  37. Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience

    Annals of Hematology, 2020

    DOI 10.1007/s00277-020-04077-4 PMID 32507911 17 Zitationen (Europe PMC) Quelle: OpenAlex

  38. Ibrutinib As a Promising Treatment for Pulmonary Complications Due to Refractory Chronic Graft Versus Host Disease

    Transplantation and Cellular Therapy, 2020

    DOI 10.1016/j.bbmt.2019.12.757 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  39. A New Hope in the Treatment of steroid-refractory Graft Versus Host Disease (Sr-GVHD) after Allogeneic Hematopoetic Stem Cell Transplantation (AHSCT): Ruxolitinib

    BONE MARROW TRANSPLANTATION, 2020

    Quelle: ORCID

  40. A single center cohort of 40 severe covid-19 patients who were treated with convalescent plasma

    Turkish Journal of Medical Sciences, 2020

    DOI 10.3906/sag-2009-77 PMID 33078604 6 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  41. Epidemiology and Clinical Features of Febrile Neutropenic Episodes: Three Years Experience at Hematology Wards

    BONE MARROW TRANSPLANTATION, 2020

    Quelle: ORCID

  42. COVID-19 Enfeksiyonlarında İmmun Plazma Tedavisi ve Sonuçları

    Sağlık Bilimlerinde İleri Araştırmalar Dergisi / Journal of Advanced Research in Health Sciences, 2020

    DOI 10.26650/jarhs2020-s1-0009 Frei zugänglicher VolltextQuelle: OpenAlex

  43. Hematopoietik Kök Hücre Nakli Hastalarında Etkileşimsel Eğitim Yaklaşımının Anksiyete Düzeyine Etkisi

    DergiPark (Istanbul University), 2020

    Frei zugänglicher VolltextQuelle: OpenAlex

  44. PS1245 NIVOLUMAB FOR RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: LONG TERM RESULTS OF MULTI‐CENTER EXPERIENCE IN TURKEY

    HemaSphere, 2019

    DOI 10.1097/01.hs9.0000563260.18006.d6 Frei zugänglicher VolltextQuelle: OpenAlex

  45. Nivolumab for relapsed or refractory Hodgkin lymphoma: long term results of multi-center experience in Turkey

    AYBU AVESIS, 2019

    Quelle: OpenAlex

  46. Relaps/Refrakter Hodgkin Lenfomada Nivolumab: Çok Merkezli Türkiye Deneyimi Uzun Dönem Sonuçları

    AYBU AVESIS, 2019

    Quelle: OpenAlex

  47. PS1556 BRUTON TYROSINE KINASE INHIBITOR IS AN EFFECTIVE STEROID‐SPARING AGENT IN CHRONIC GRAFT‐VERSUS‐HOST DISEASE

    HemaSphere, 2019

    DOI 10.1097/01.hs9.0000564480.84127.74 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  48. A rare complication of hematopoietic stem cell transplantation: Kaposi sarcoma

    LEUKEMIA RESEARCH, 2019

    DOI 10.1016/s0145-2126(19)30332-7 1 Zitation (OpenAlex) Quelle: ORCID

  49. Adult Case Series of Extramedullary Relapsing Acute Myeloid Leukemia (AML) after Allogeneic Stem Cell Transplantation in Whom a Rapid Response and a Reasonably Long Remission Could be Achieved with Gemtuzumab Ozogamycin (GO)

    BLOOD, 2019

    DOI 10.1182/blood-2019-126195 1 Zitation (OpenAlex) Quelle: ORCID

  50. Comparison of outcomes of total body irradiation (TBI) vs non-TBI conditioning regimens in acute lymphoblastic leukemia for allogeneic transplantation

    BONE MARROW TRANSPLANTATION, 2019

    Quelle: ORCID